Nuvisan GmbH

“"Our company worked very closely with Nuvisan in 2024. Nuvisan conducted several of our clinical pharma studies from different programs, and all studies were completed on time and with high quality."”

““Our experience working with Nuvisan's Radiochemistry and DMPK experts has been very positive. Communication with the team was excellent, their technical expertise impressive, and any challenges were addressed swiftly by them. We especially appreciated that we were always kept well informed throughout the collaboration.””

““Our collaboration with Nuvisan has been a great success. The seamless integration of their phase I unit with next-door bioanalytical capabilities has provided unparalleled efficiency and precision for our project. Their ability to combine preclinical activities with expert support in metabolism profiling has been a game-changer for our development program. Their expertise and commitment are highly valued, making them a trusted partner."”

“"We highly recommend Nuvisan to anyone seeking a reliable partner for in vivo efficacy studies. We appreciate their excellent experimental capacities and study management, as well as open and constructive scientific discussions that allow us to collaborate efficiently on multiple projects. Their dedication, flexibility, and quality make them an invaluable support in our preclinical drug development."”

““We are very happy to have your support always at the highest professional level. […] Your comprehensive analysis of the available data, coupled with your insightful recommendations, have been extremely valuable. I deeply appreciate the effort and attention to detail you put into preparing for our discussion. As always, your expertise has helped us better understand compound-related concerns, and we received good advice on what to do next.””

““Nuvisan was able to meet our needs with a deep understanding of the challenges faced by French biotech companies. Their Clinical Trial Supplies (CTS) services enabled us to conduct our phase 2 clinical trial smoothly and quickly. Their solutions are tailored to our size and ambitions, offering exceptional flexibility and responsiveness. Nuvisan is a true strategic partner for any biotech company seeking high-quality services.””

““Our collaboration with Nuvisan turned a major scientific challenge into a breakthrough. Using cryo-EM, Nuvisan determined a series of structures of a multi-protein transmembrane complex in remarkable detail — best resolution 1.9 Å, average < 2.2 Å — giving us the insights we needed to advance our research with confidence. What made this partnership stand out was the scientific excellence paired with the ability to deliver solutions to overcome roadblocks, genuine transparency, and a shared drive to deliver. We look forward to continuing this journey together."”